Tag: Longevity

7 predictions tagged with "Longevity".

The First Efficacy Results From The TAME (Targeting Aging With Metformin) Trial Are Expected To Be Published Between 2027 And 2028, Providing The First Strong Signal On Whether Metformin Delays The First Onset Of Age-related Diseases In Non-diabetic Adults Aged 65-79.
Drugs That Regulate The Circadian Rhythm (Biological Clock) Are Expected To Be Developed.
Wearable Devices For Sleep Optimization Are Expected To Become Widespread.
Anti-aging Molecules (Senolytics) Are Expected To Show Promising Results In Clinical Trials.
Sleep Tracking Devices (Such As The Oura Ring) Are Expected To Gain Independent Clinical Validation And Regulatory Clarity On Sleep-stage Accuracy By 2028, With Device Data From Millions Of Users Increasingly Integrated Into Primary Care Monitoring.
Interim Results From The First Large Human Trials Testing Whether GLP-1 Drugs (Such As Semaglutide) Slow Aging Are Expected By 2031, Clarifying Whether These Drugs, Which Extended Mouse Lifespan By About 12 Percent, Affect Biological Aging Markers In Humans.
At Least One AI-discovered Drug Candidate Aimed At Extending Lifespan Is Expected To Enter Human Clinical Trials By 2034, With Tools Such As AlphaFold Compressing Drug Discovery Timelines From Years To Months.